Upregulation of Fas and downregulation of CD94?NKG2A inhibitory receptors on circulating natural killer cells in patients with new-onset psoriasis

British Journal of Dermatology

Volumn 161, Issue 2, 2009, Pages 281-288

  Son, S W ^a   Kim, E O ^b   Ryu, E S ^b   Kim, T J ^b   Kim, J N ^a   Choi, J E ^a   Kye, Y C ^a   Lee, K M ^b  

^a Laboratory of Molecular and Cellular Biology   (South Korea)

^b Korea University College of Medicine   (South Korea)

Author keywords

CD94?NKG2A; Fas; Natural killer cells; NK activating receptors; NK inhibitory receptors; Psoriasis

Indexed keywords

FAS ANTIGEN; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY C; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY D;

ADOLESCENT; ADULT; ARTICLE; CELL COUNT; CYTOLOGY; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOLOGY; MALE; METABOLISM; NATURAL KILLER CELL; NATURAL KILLER T CELL; PSORIASIS; SKIN; UPREGULATION;

ADOLESCENT; ADULT; ANTIGENS, CD95; CELL COUNT; DOWN-REGULATION; FEMALE; FLOW CYTOMETRY; HUMANS; KILLER CELLS, NATURAL; MALE; NATURAL KILLER T-CELLS; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY C; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY D; PSORIASIS; SKIN; UP-REGULATION;

EID: 73349140522     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2009.09178.x     Document Type: Article

References (41)

1. Lowes MA, Bowcock AM, Krueger JG. Pathogenesis and therapy of psoriasis. Nature 2007; 445:866-73.
2. Griffiths C, Voorhees J. Psoriasis, T cells and autoimmunity. J R Soc Med 1996; 89:315-19.
3. Valdimarsson H, Baker BS, Jonsdottir I et al. Psoriasis: a T-cell-mediated autoimmune disease induced by streptococcal superantigens? Immunol Today 1995; 16:145-9.
4. Menssen A, Trommler P, Vollmer S et al. Evidence for an antigenspecific cellular immune response in skin lesions of patients with psoriasis vulgaris. J Immunol 1995; 155:4078-83.
5. Cameron AL, Kirby B, Fei W et al. Natural killer and natural killer- T cells in psoriasis. Arch Dermatol Res 2002; 294:363-9.
6. Schlaak JF, Buslau M, Jochum W et al. T cells involved in psoriasis vulgaris belong to the Th1 subset. J Invest Dermatol 1994; 102:145-9.
7. Yawalkar N, Karlen S, Hunger R et al. Expression of interleukin-12 is increased in psoriatic skin. J Invest Dermatol 1998; 111:1053-7.
8. Berner B, Akca D, Jung T et al. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry. J Rheumatol 2000; 27:1128-35.
9. Karpuj MV, Steinman L, Oksenberg JR. Multiple sclerosis: a polygenic disease involving epistatic interactions, germline rearrangements and environmental effects. Neurogenetics 1997; 1:21-8.
10. Kukreja A, Maclaren NK. Autoimmunity and diabetes. J Clin Endocrinol Metab 1999; 84:4371-8.
11. Akahoshi M, Nakashima H, Tanaka Y et al. Th1?Th2 balance of peripheral T helper cells in systemic lupus erythematosus. Arthritis Rheum 1999; 42:1644-8.
12. Cameron AL, Kirby B, Griffiths CE. Circulating natural killer cells in psoriasis. Br J Dermatol 2003; 149:160-4.
13. Koreck A, Suranyi A, Szony BJ et al. CD3+CD56+ NK T cells are significantly decreased in the peripheral blood of patients with psoriasis. Clin Exp Immunol 2002; 127:176-82.
14. Asahina A, Akazaki S, Nakagawa H et al. Specific nucleotide sequence of HLA-C is strongly associated with psoriasis vulgaris. J Invest Dermatol 1991; 97:254-8.
15. Gilhar A, Ullmann Y, Kerner H et al. Psoriasis is mediated by a cutaneous defect triggered by activated immunocytes: induction of psoriasis by cells with natural killer receptors. J Invest Dermatol 2002; 119:384-91.
16. brightCD16(-) NK cells accumulate in psoriatic skin in response to CXCL10 and CCL5 and exacerbate skin inflammation. Eur J Immunol 2006; 36:118-28.
17. Lee HJ, Choi SC, Choi EY et al. Iron chelator induces MIPalpha?CCL20 in human intestinal epithelial cells: implication for triggering mucosal adaptive immunity. Exp Mol Med 2005; 37:297-310.
18. Bauer S, Groh V, Wu J et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999; 285:727-9.
19. Cosman D, Mullberg J, Sutherland CL et al. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 2001; 14:123-33.
20. Nakajima H, Cella M, Langen H et al. Activating interactions in human NK cell recognition: the role of 2B4-CD48. Eur J Immunol 1999; 29:1676-83.
21. Robertson M, Caligiuri M, Manley T et al. Human natural killer cell adhesion molecules. Differential expression after activation and participation in cytolysis. J Immunol 1990; 145:3194-201.
22. Dhein J, Walczak H, Baumler C et al. Autocrine T-cell suicide mediated by APO-1?(Fas?CD95). Nature 1995; 373:438-41.
23. Ju S-T, Panka DJ, Cui H et al. Fas(CD95)?FasL interactions required for programmed cell death after T-cell activation. Nature 1995; 373:444-8.
24. Lenardo MJ, Boehme S, Chen L et al. Autocrine feedback death and the regulation of mature T lymphocyte antigen responses. Int Rev Immunol 1995; 13:115-34.
25. Lenardo M, Chan KM, Hornung F et al. Mature T lymphocyte apoptosis - immune regulation in a dynamic and unpredictable antigenic environment. Annu Rev Immunol 1999; 17:221-53.
26. Wu J, Zhou T, Zhang J et al. Correction of accelerated autoimmune disease by early replacement of the mutated lpr gene with the normal Fas apoptosis gene in the T cells of transgenic MRL-lpr?lpr mice. Proc Natl Acad Sci USA 1994; 91:2344-8.
27. Mysler E, Bini P, Drappa J et al. The apoptosis-1?Fas protein in human systemic lupus erythematosus. J Clin Invest 1994; 93:1029-34.
28. Takahashi K, Aranami T, Endoh M et al. The regulatory role of natural killer cells in multiple sclerosis. Brain 2004; 127:1917-27.
29. Liao YH, Jee SH, Sheu BC et al. Increased expression of the natural killer cell inhibitory receptor CD94?NKG2A and CD158b on circulating and lesional T cells in patients with chronic plaque psoriasis. Br J Dermatol 2006; 155:318-24.
30. Wrone-Smith T, Johnson T, Nelson B et al. Discordant expression of Bcl-x and Bcl-2 by keratinocytes in vitro and psoriatic keratinocytes in vivo. Am J Pathol 1995; 146:1079-88.
31. Gilhar A, Yaniv R, Assy B et al. Fas pulls the trigger on psoriasis. Am J Pathol 2006; 168:170-5.
32. Cheng J, Zhou T, Liu C et al. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 1994; 263:1759-62.
33. Jackson AM, Alexandrov AB, Gribben SC et al. Expression and shedding of ICAM-1 in bladder cancer and its immunotherapy. Int J Cancer 1993; 55:921-5.
34. Pearl-Yafe M, Stein J, Yolcu ES et al. Fas transduces dual apoptotic and trophic signals in hematopoietic progenitors. Stem Cells 2007; 25:3194-203.
35. Bos JD, de Rie MA, Teunissen MB et al. Psoriasis: dysregulation of innate immunity. Br J Dermatol 2005; 152:1098-107.
36. Nickoloff BJ, Wrone-Smith T, Bonish B et al. Response of murine and normal human skin to injection of allogeneic blood-derived psoriatic immunocytes: detection of T cells expressing receptors typically present on natural killer cells, including CD94, CD158, and CD161. Arch Dermatol 1999; 135:546-52.
37. Nickoloff BJ, Bonish B, Huang BB et al. Characterization of a T cell line bearing natural killer receptors and capable of creating psoriasis in a SCID mouse model system. J Dermatol Sci 2000; 24:212-25.
38. Boyman O, Hefti HP, Conrad C et al. Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-alpha. J Exp Med 2004; 199:731-6.
39. van der Vliet HJ, von Blomberg BM, Nishi N et al. Circulating V(alpha24+) Vbeta11+ NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage. Clin Immunol 2001; 100:144-8.
40. Kastrukoff LF, Morgan NG, Zecchini D et al. A role for natural killer cells in the immunopathogenesis of multiple sclerosis. J Neuroimmunol 1998; 86:123-33.
41. Negishi K, Waldeck N, Chandy G et al. Natural killer cell and islet killer cell activities in type 1 (insulin-dependent) diabetes. Diabetologia 1986; 29:352-7.